利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

58 条记录 (耗时 0.045 秒)

    Network interface card accessible during low power consumption mode
    1.
    发明授权
    Network interface card accessible during low power consumption mode 失效
    网络接口卡在低功耗模式下可访问

    公开(公告)号：US06513128B1

    公开(公告)日：2003-01-28

    申请号：US09451485

    申请日：1999-11-30

    申请人： Chi-Lie Wang ,  Eric Davis ,  Nathan Henderson ,  Jeffrey Ross

    发明人： Chi-Lie Wang ,  Eric Davis ,  Nathan Henderson ,  Jeffrey Ross

    IPC分类号： G06F104

    CPC分类号： G06F1/32

    摘要： The present invention allows NIC resources to be accessed through auxiliary power and an ASIC clock while the PC is powered down and while PCI power and the PCI clock are not available. The present invention also provides an alternate path for accessing the NIC registers, downloading keep-alive and alert-on-LAN packets to the transmit packet buffer (TPB), as well as uploading received packets from the receive packet buffer (RPB). The present invention also allows monitoring PCI activity and seamlessly servicing the PCI configuration cycle (when PCI power and the PCI clock are restored) in conjunction with responding to the access through the alternate path (while PCI power and the PCI clock are not available).

    摘要翻译： 本发明允许通过辅助电源和ASIC时钟来访问NIC资源，同时PC断电，而PCI电源和PCI时钟不可用。 本发明还提供了一种用于访问NIC寄存器，向POP发送缓冲器（TPB）下载保持活动和LAN报警信息的备用路径，以及从接收分组缓冲器（RPB）上传接收的分组。 本发明还允许监视PCI活动并且无缝地服务于PCI配置周期（当PCI电力和PCI时钟被恢复时），同时响应于通过备用路径的访问（当PCI电源和PCI时钟不可用时）。

    Method and apparatus to modulate cellular regeneration post myocardial infarct
    4.
    发明授权
    Method and apparatus to modulate cellular regeneration post myocardial infarct 失效
    调节心肌梗塞后细胞再生的方法和装置

    公开(公告)号：US07764995B2

    公开(公告)日：2010-07-27

    申请号：US10862716

    申请日：2004-06-07

    申请人： Steven D. Girouard ,  Jeffrey Ross ,  Rodney W. Salo

    发明人： Steven D. Girouard ,  Jeffrey Ross ,  Rodney W. Salo

    IPC分类号： A61N1/36

    CPC分类号： A61M5/14276 ,  A61M5/1723 ,  A61M2205/3523 ,  A61M2205/3561 ,  A61M2210/125 ,  A61M2230/00 ,  A61N1/36585

    摘要： A system delivers cardiac pacing therapy and chemical and/or biological therapy to modulate myocardial tissue growth in a heart after myocardial infarction (MI). The system includes an agent delivery device to release one or more agents to an MI region to modulate myocardial tissue growth in that region, and a cardiac rhythm management (CRM) device to deliver pacing pulses to enhance the effects of the one or more agents by altering myocardial wall stress and cardiac workload. In one embodiment, the system is an implantable system including an implantable agent delivery device and an implantable CRM device.

    摘要翻译： 系统提供心脏起搏治疗和化学和/或生物治疗以调节心肌梗塞（MI）后心脏中的心肌组织生长。 该系统包括用于将一个或多个药剂释放到MI区域以调节该区域中的心肌组织生长的药剂递送装置，以及心律管理（CRM）装置，以递送起搏脉冲以增强一种或多种药剂的作用 改变心肌壁压力和心脏工作量。 在一个实施例中，该系统是包括可植入药剂输送装置和可植入CRM装置的可植入系统。

    Methods and compositions to treat myocardial conditions
    8.
    发明授权
    Methods and compositions to treat myocardial conditions 有权
    治疗心肌病症的方法和组合物

    公开(公告)号：US07294334B1

    公开(公告)日：2007-11-13

    申请号：US10802955

    申请日：2004-03-16

    申请人： Eugene T. Michal ,  Jeffrey Ross

    发明人： Eugene T. Michal ,  Jeffrey Ross

    IPC分类号： C12N5/06

    CPC分类号： A61N1/3625 ,  A61K9/0024 ,  A61K31/00 ,  A61K31/728 ,  A61K31/732 ,  A61K31/734 ,  A61K31/78 ,  A61K31/79 ,  A61K36/886 ,  A61K38/40 ,  A61K41/0042 ,  A61K45/06 ,  A61K47/02 ,  A61K47/34 ,  A61K47/60 ,  A61K47/62 ,  A61K49/0404 ,  A61L24/043 ,  A61L27/20 ,  A61L27/50 ,  A61L27/54 ,  A61L2430/20 ,  A61N1/36521 ,  A61K2300/00

    摘要： Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle using a combination of therapies. The method may include the introduction of structurally reinforcing agents. In other embodiments, agents may be introduced into a ventricle to increase compliance of the ventricle. The prevention of remodeling may include the prevention of thinning of the ventricular infarct zone. Another embodiment includes the reversing or prevention of ventricular remodeling with electro-stimulatory therapy. The unloading of the stressed myocardium over time effects reversal of undesirable ventricular remodeling. These therapies may be combined with structurally reinforcing therapies. In other embodiments, the structurally reinforcing component may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.

    摘要翻译： 用于治疗心肌梗塞的方法，装置，试剂盒和组合物。 在一个实施方案中，该方法包括使用疗法的组合来防止心室梗死区的重塑。 该方法可以包括引入结构上增强剂。 在其它实施方案中，可将药剂引入心室以增加心室的依从性。 预防重塑可能包括防止心室梗死区变薄。 另一个实施方案包括用电刺激治疗逆转或预防心室重构。 随着时间的推移，应力心肌的卸载会影响不良心室重构的逆转。 这些治疗方法可能与结构加强疗法相结合。 在其它实施方案中，结构上增强组分可以伴随其它治疗剂。 这些药剂可以包括但不限于前成纤维细胞和血管生成剂。

    Method and apparatus for device controlled gene expression for cardiac protection
    9.
    发明申请
    Method and apparatus for device controlled gene expression for cardiac protection 有权
    心脏保护装置控制基因表达的方法和装置

    公开(公告)号：US20070054871A1

    公开(公告)日：2007-03-08

    申请号：US11220397

    申请日：2005-09-06

    申请人： Joseph Pastore ,  Jeffrey Ross ,  Tamara Baynham ,  Rodney Salo ,  Andrew Kramer ,  Julio Spinelli

    发明人： Joseph Pastore ,  Jeffrey Ross ,  Tamara Baynham ,  Rodney Salo ,  Andrew Kramer ,  Julio Spinelli

    IPC分类号： A61K48/00 ,  A61N1/00

    CPC分类号： A61N1/3627 ,  A61K48/0083 ,  A61N1/36514

    摘要： A gene regulatory system detects ischemia events and is capable of delivering a biologic therapy in response to the detection of an ischemic event or the reception of a command. The biologic therapy protects the heart from ischemic damage by regulating the expression of an exogenously introduced gene product. In one embodiment, the gene regulatory system includes an implantable system that emits at least one gene regulatory signal in response to the detection of the ischemic event or the reception of the command. The gene regulatory signal directly or indirectly regulates gene expression of the gene product.

    摘要翻译： 基因调控系统检测缺血事件，并且能够响应于缺血事件的检测或命令的接收而递送生物疗法。 生物治疗通过调节外源基因产物的表达来保护心脏免于缺血性损伤。 在一个实施方案中，基因调控系统包括可植入系统，其可以响应于缺血事件的检测或命令的接收而发射至少一个基因调节信号。 基因调控信号直接或间接调控基因产物的基因表达。

    Servo driven draw roll for bag machine
    10.
    发明授权
    Servo driven draw roll for bag machine 失效
    伺服驱动牵引辊

    公开(公告)号：US5000727A

    公开(公告)日：1991-03-19

    申请号：US270889

    申请日：1988-11-14

    申请人： Peter Hatchell ,  Charles A. Sample ,  Jeffrey Ross

    发明人： Peter Hatchell ,  Charles A. Sample ,  Jeffrey Ross

    IPC分类号： B31B1/96 ,  B31B19/10 ,  B65H23/192

    CPC分类号： B31B19/00 ,  B31B2219/022

    摘要： A machine for the continuous production of plastic bags utilizes a servo drive motor to drive the machines film web draw roll assembly and through a seal roll index gear also to drive a seal roll of the machine in coordination with the servo driven draw roll. Control of the servo motor is through a motion controller receiving inputs form the servo motor.

    摘要翻译： 用于连续生产塑料袋的机器利用伺服驱动电机来驱动机器薄膜卷筒纸组件并通过密封辊分度齿轮，以与伺服驱动牵引辊协调地驱动机器的密封辊。 伺服电机的控制是通过运动控制器从伺服电机接收输入。